Literature DB >> 8055757

Effects and control of highland malaria epidemic in Uasin Gishu District, Kenya.

E S Some1.   

Abstract

This report documents the effects of malaria epidemic and how it was controlled in one highland district of Kenya. The effects of the epidemic are presented in terms of mortality, morbidity and school absenteeism; information is from routine and verbal reports. Treatment with chloroquine, amodiaquine and sulphonamide pyrimethamine combinations, limited vector control, and health education were used to control the epidemic. Hospital mortality per month increased by 8.6 times during the epidemic while morbidity went up by 3.7 times. Of the 103 deaths attributed to malaria, 64 (62.1%) occurred in hospital and 39 (37.9%) at home. Most of the home deaths (92.3%), occurred in areas that border the malaria endemic Lake Victoria Basin. The rate of pupil absenteeism ranged from 17.6% to 54.4% in primary schools. The policy implications of the report are discussed.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Epidemics; Epidemiologic Methods; Health; Kenya; Malaria--prevention and control; Parasite Control; Parasitic Diseases; Public Health; Technical Report; Treatment

Mesh:

Substances:

Year:  1994        PMID: 8055757

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  19 in total

1.  Association between climate variability and malaria epidemics in the East African highlands.

Authors:  Guofa Zhou; Noboru Minakawa; Andrew K Githeko; Guiyun Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

2.  Effect of swamp cultivation on distribution of anopheline larval habitats in Western Kenya.

Authors:  Elizabeth Omukunda; Andrew Githeko; Millicent F Ndong A; Emmanuel Mushinzimana; Guiyun Yan
Journal:  J Vector Borne Dis       Date:  2012-06       Impact factor: 1.688

3.  Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya.

Authors:  C C John; P O Sumba; J H Ouma; B L Nahlen; C L King; J W Kazura
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

4.  Investigations on anopheline mosquitoes close to the nest sites of chimpanzees subject to malaria infection in Ugandan highlands.

Authors:  Sabrina Krief; Florence Levrero; Jean-Michel Krief; Supinya Thanapongpichat; Mallika Imwong; Georges Snounou; John M Kasenene; Marie Cibot; Jean-Charles Gantier
Journal:  Malar J       Date:  2012-04-17       Impact factor: 2.979

5.  The economic costs of malaria in four Kenyan districts: do household costs differ by disease endemicity?

Authors:  Jane Chuma; Vincent Okungu; Catherine Molyneux
Journal:  Malar J       Date:  2010-06-02       Impact factor: 2.979

6.  Clinical epidemiology of malaria in the highlands of western Kenya.

Authors:  Simon I Hay; Abdisalan M Noor; Milka Simba; Millie Busolo; Helen L Guyatt; Sam A Ochola; Robert W Snow
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

7.  Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya.

Authors:  Chandy C John; Joseph S Zickafoose; P Odada Sumba; Christopher L King; James W Kazura
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Malaria in East African highlands during the past 30 years: impact of environmental changes.

Authors:  Yousif E Himeidan; Eliningaya J Kweka
Journal:  Front Physiol       Date:  2012-08-02       Impact factor: 4.566

Review 9.  Response to malaria epidemics in Africa.

Authors:  Tarekegn A Abeku
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

10.  Meteorologic influences on Plasmodium falciparum malaria in the Highland Tea Estates of Kericho, Western Kenya.

Authors:  G Dennis Shanks; Simon I Hay; David I Stern; Kimutai Biomndo; Robert W Snow
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.